Oxop D Eye Drop is a sterile ophthalmic solution combining Ofloxacin (0.3% w/v), a broad-spectrum fluoroquinolone antibiotic, and Dexamethasone (0.1% w/v), a potent corticosteroid. This formulation is indicated for the treatment of bacterial infections of the eye accompanied by inflammatory conditions such as conjunctivitis, keratitis, blepharitis, and postoperative ocular inflammation. Ofloxacin exerts its antibacterial effect by inhibiting bacterial DNA gyrase and topoisomerase IV, thereby preventing bacterial replication and effectively eradicating susceptible gram-positive and gram-negative pathogens. Dexamethasone provides anti-inflammatory and immunosuppressive actions by inhibiting multiple inflammatory cytokines, reducing edema, redness, and pain associated with ocular infections. Oxop D Eye Drop should be used under strict medical supervision to ensure appropriate diagnosis and to prevent potential complications such as fungal superinfection or steroid-induced ocular hypertension. The recommended dosage typically involves instillation of one or two drops into the affected eye(s) every four to six hours; however, the regimen may be adjusted based on clinical response. Caution is advised in patients with a history of glaucoma, viral eye infections, or hypersensitivity to any component. Proper administration technique and adherence to prescribed duration are essential to maximize therapeutic outcomes and minimize adverse effects.